A detailed history of World Equity Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, World Equity Group, Inc. holds 65,953 shares of PFE stock, worth $1.76 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
65,953
Previous 57,763 14.18%
Holding current value
$1.76 Million
Previous $1.62 Billion 18.09%
% of portfolio
0.69%
Previous 0.48%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$27.7 - $31.39 $226,863 - $257,084
8,190 Added 14.18%
65,953 $1.91 Billion
Q2 2024

Jul 18, 2024

SELL
$25.26 - $29.6 $1.12 Million - $1.31 Million
-44,349 Reduced 43.43%
57,763 $1.62 Billion
Q1 2024

Jul 18, 2024

BUY
$25.89 - $29.73 $2.64 Million - $3.04 Million
102,112 New
102,112 $2.83 Billion
Q4 2023

Jul 22, 2024

BUY
$26.13 - $33.94 $212,332 - $275,796
8,126 Added 11.16%
80,964 $2.76 Billion
Q3 2023

Jul 22, 2024

BUY
$32.09 - $37.51 $483,756 - $565,463
15,075 Added 26.1%
72,838 $2.42 Billion
Q2 2023

Aug 26, 2024

SELL
$36.12 - $41.79 $3.67 Million - $4.24 Million
-101,481 Reduced 74.26%
35,183 $1.29 Billion
Q1 2023

Aug 26, 2024

BUY
$39.39 - $51.28 $3.11 Million - $4.05 Million
78,901 Added 136.59%
136,664 $3.51 Billion
Q4 2022

Sep 06, 2024

BUY
$41.75 - $54.5 $32,648 - $42,619
782 Added 2.04%
39,111 $2 Billion
Q3 2022

Sep 06, 2024

SELL
$43.76 - $53.42 $850,431 - $1.04 Million
-19,434 Reduced 33.64%
38,329 $1.68 Billion
Q2 2022

Sep 06, 2024

SELL
$46.53 - $55.17 $320,079 - $379,514
-6,879 Reduced 15.59%
37,246 $1.95 Billion
Q1 2022

Sep 06, 2024

SELL
$45.75 - $56.69 $623,938 - $773,138
-13,638 Reduced 23.61%
44,125 $2.28 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track World Equity Group, Inc. Portfolio

Follow World Equity Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on World Equity Group, Inc. with notifications on news.